Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

China · Delayed Price · Currency is CNY

19.98

+0.23 (1.16%)

At close: Jun 18, 2026

-22.17% (1Y)

Market Cap	8.22B -22.5%
Revenue (ttm)	1.31B -21.8%
Net Income	57.66M -82.7%
EPS	0.14 -82.3%
Shares Out	411.25M
PE Ratio	140.00
Forward PE	44.40
Dividend	0.10 (0.50%)
Ex-Dividend Date	Jun 3, 2026

Volume	2,284,677
Open	19.73
Previous Close	19.75
Day's Range	19.53 - 20.18
52-Week Range	19.53 - 29.63
Beta	0.42
Analysts	n/a
Price Target	33.00 (+65.17%)
Earnings Date	Aug 28, 2026

About SHA:688739

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use worldwide. It offers inactivated Japanese encephalitis vaccine (IJEV) and SPEEDA-rabies vaccine. The company’s rabies and influenza vaccines are in the new drug application stage; haemophilus influenzae type b vaccine in phase III; recombinant human papillomavirus 15-valent vaccine is in phase II; and 13-valent pneumococcal polysaccharide conjugate and varicella, as well as the live meningococ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 1,781

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688739

Full Company Profile

Financial Performance

In 2025, SHA:688739's revenue was 1.39 billion, a decrease of -17.06% compared to the previous year's 1.68 billion. Earnings were 131.79 million, a decrease of -61.56%.

Financial Statements